Pharma Exec spoke with CEO Faruk Capan on all the positives, negatives, hopes, and fears attached to generative AI for us as regular humans, and as pharma marketers.
Related Posts
02|16|23
Inside EVERSANA INTOUCH’s AI-Focused Ad Campaign
Pharma Exec spoke with CEO Faruk Capan on all the positives, negatives, hopes, and fears attached to generative AI for us as regular humans, and as pharma marketers.
02|16|23
Can a Celebrity Influencer Work for Your Brand?
Pharma Exec spoke with CEO Faruk Capan on all the positives, negatives, hopes, and fears attached to generative AI for us as regular humans, and as pharma marketers.
02|16|23
OpenAI’s New o1 Series Models’ Focus on “Reasoning” and What It Could Mean to Lifesciences Brands and Marketers
Pharma Exec spoke with CEO Faruk Capan on all the positives, negatives, hopes, and fears attached to generative AI for us as regular humans, and as pharma marketers.